 | • レポートコード：B-GIR08C0160 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、アレクチニブの世界市場について調べ、まとめました。種類別セグメントは、150mg×140カプセル、150mg×28等、用途別セグメントは、切除不能NSCLC、アドバンストNSCLC、リカレントNSCLC、その他等に区分しました。アレクチニブの世界市場概観、企業動向、企業別アレクチニブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アレクチニブの市場概観 ・アレクチニブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アレクチニブの企業別販売動向、市場シェア、市場集中度、競争動向 ・アレクチニブの世界市場規模 ・アレクチニブの北米市場分析（アメリカ、カナダ、メキシコ等） ・アレクチニブのアメリカ市場規模推移 ・アレクチニブのカナダ市場規模推移 ・アレクチニブのメキシコ市場規模推移 ・アレクチニブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・アレクチニブのドイツ市場規模推移 ・アレクチニブのイギリス市場規模推移 ・アレクチニブのロシア市場規模推移 ・アレクチニブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・アレクチニブの日本市場規模推移 ・アレクチニブの中国市場規模推移 ・アレクチニブの韓国市場規模推移 ・アレクチニブのインド市場規模推移 ・アレクチニブの東南アジア市場規模推移 ・アレクチニブの南米市場分析（ブラジル、アルゼンチン等） ・アレクチニブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・アレクチニブの種類別分析/販売量、売上、市場シェア（150mg×140カプセル、150mg×28） ・アレクチニブの用途別分析/市場規模（切除不能NSCLC、アドバンストNSCLC、リカレントNSCLC、その他） ・アレクチニブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・アレクチニブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Alectinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Alectinib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Roche
Everest Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
150mg*140 Capsules
150mg*28 Capsules
20mg*1 Capsule
40mg*1 Capsule
150mg*26 Capsules
Market Segment by Applications, can be divided into
Unresectable NSCLC
Advanced NSCLC
Recurrent NSCLC
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alectinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alectinib, with price, sales, revenue and global market share of Alectinib in 2017 and 2018.
Chapter 3, the Alectinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alectinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Alectinib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Alectinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Alectinib Introduction
1.2 Market Analysis by Type
1.2.1 150mg*140 Capsules
1.2.2 150mg*28 Capsules
1.2.3 20mg*1 Capsule
1.2.4 40mg*1 Capsule
1.2.5 150mg*26 Capsules
1.3 Market Analysis by Applications
1.3.1 Unresectable NSCLC
1.3.2 Advanced NSCLC
1.3.3 Recurrent NSCLC
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Alectinib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Alectinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Everest Pharmaceuticals
2.2.1 Business Overview
2.2.2 Alectinib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Everest Pharmaceuticals Alectinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Alectinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Alectinib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Alectinib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Alectinib Manufacturer Market Share in 2018
3.3.2 Top 6 Alectinib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Alectinib Market Analysis by Regions
4.1 Global Alectinib Sales, Revenue and Market Share by Regions
4.1.1 Global Alectinib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Alectinib Revenue and Market Share by Regions (2014-2019)
4.2 North America Alectinib Sales and Growth Rate (2014-2019)
4.3 Europe Alectinib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Alectinib Sales and Growth Rate (2014-2019)
4.5 South America Alectinib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Alectinib Sales and Growth Rate (2014-2019)
5 North America Alectinib by Country
5.1 North America Alectinib Sales, Revenue and Market Share by Country
5.1.1 North America Alectinib Sales and Market Share by Country (2014-2019)
5.1.2 North America Alectinib Revenue and Market Share by Country (2014-2019)
5.2 United States Alectinib Sales and Growth Rate (2014-2019)
5.3 Canada Alectinib Sales and Growth Rate (2014-2019)
5.4 Mexico Alectinib Sales and Growth Rate (2014-2019)
6 Europe Alectinib by Country
6.1 Europe Alectinib Sales, Revenue and Market Share by Country
6.1.1 Europe Alectinib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Alectinib Revenue and Market Share by Country (2014-2019)
6.2 Germany Alectinib Sales and Growth Rate (2014-2019)
6.3 UK Alectinib Sales and Growth Rate (2014-2019)
6.4 France Alectinib Sales and Growth Rate (2014-2019)
6.5 Russia Alectinib Sales and Growth Rate (2014-2019)
6.6 Italy Alectinib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Alectinib by Country
7.1 Asia-Pacific Alectinib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Alectinib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Alectinib Revenue and Market Share by Country (2014-2019)
7.2 China Alectinib Sales and Growth Rate (2014-2019)
7.3 Japan Alectinib Sales and Growth Rate (2014-2019)
7.4 Korea Alectinib Sales and Growth Rate (2014-2019)
7.5 India Alectinib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Alectinib Sales and Growth Rate (2014-2019)
8 South America Alectinib by Country
8.1 South America Alectinib Sales, Revenue and Market Share by Country
8.1.1 South America Alectinib Sales and Market Share by Country (2014-2019)
8.1.2 South America Alectinib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Alectinib Sales and Growth Rate (2014-2019)
8.3 Argentina Alectinib Sales and Growth Rate (2014-2019)
8.4 Colombia Alectinib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Alectinib by Countries
9.1 Middle East and Africa Alectinib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Alectinib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Alectinib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Alectinib Sales and Growth Rate (2014-2019)
9.3 Turkey Alectinib Sales and Growth Rate (2014-2019)
9.4 Egypt Alectinib Sales and Growth Rate (2014-2019)
9.5 Nigeria Alectinib Sales and Growth Rate (2014-2019)
9.6 South Africa Alectinib Sales and Growth Rate (2014-2019)
10 Global Alectinib Market Segment by Type
10.1 Global Alectinib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Alectinib Sales and Market Share by Type (2014-2019)
10.1.2 Global Alectinib Revenue and Market Share by Type (2014-2019)
10.2 150mg*140 Capsules Sales Growth and Price
10.2.1 Global 150mg*140 Capsules Sales Growth (2014-2019)
10.2.2 Global 150mg*140 Capsules Price (2014-2019)
10.3 150mg*28 Capsules Sales Growth and Price
10.3.1 Global 150mg*28 Capsules Sales Growth (2014-2019)
10.3.2 Global 150mg*28 Capsules Price (2014-2019)
10.4 20mg*1 Capsule Sales Growth and Price
10.4.1 Global 20mg*1 Capsule Sales Growth (2014-2019)
10.4.2 Global 20mg*1 Capsule Price (2014-2019)
10.5 40mg*1 Capsule Sales Growth and Price
10.5.1 Global 40mg*1 Capsule Sales Growth (2014-2019)
10.5.2 Global 40mg*1 Capsule Price (2014-2019)
10.6 150mg*26 Capsules Sales Growth and Price
10.6.1 Global 150mg*26 Capsules Sales Growth (2014-2019)
10.6.2 Global 150mg*26 Capsules Price (2014-2019)
11 Global Alectinib Market Segment by Application
11.1 Global Alectinib Sales Market Share by Application (2014-2019)
11.2 Unresectable NSCLC Sales Growth (2014-2019)
11.3 Advanced NSCLC Sales Growth (2014-2019)
11.4 Recurrent NSCLC Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Alectinib Market Forecast (2019-2024)
12.1 Global Alectinib Sales, Revenue and Growth Rate (2019-2024)
12.2 Alectinib Market Forecast by Regions (2019-2024)
12.2.1 North America Alectinib Market Forecast (2019-2024)
12.2.2 Europe Alectinib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Alectinib Market Forecast (2019-2024)
12.2.4 South America Alectinib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Alectinib Market Forecast (2019-2024)
12.3 Alectinib Market Forecast by Type (2019-2024)
12.3.1 Global Alectinib Sales Forecast by Type (2019-2024)
12.3.2 Global Alectinib Market Share Forecast by Type (2019-2024)
12.4 Alectinib Market Forecast by Application (2019-2024)
12.4.1 Global Alectinib Sales Forecast by Application (2019-2024)
12.4.2 Global Alectinib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Alectinib Picture
Table Product Specifications of Alectinib
Figure Global Sales Market Share of Alectinib by Types in 2018
Table Alectinib Types for Major Manufacturers
Figure 150mg*140 Capsules Picture
Figure 150mg*28 Capsules Picture
Figure 20mg*1 Capsule Picture
Figure 40mg*1 Capsule Picture
Figure 150mg*26 Capsules Picture
Figure Alectinib Sales Market Share by Applications in 2018
Figure Unresectable NSCLC Picture
Figure Advanced NSCLC Picture
Figure Recurrent NSCLC Picture
Figure Other Picture
Figure United States Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure France Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure China Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure India Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Alectinib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Alectinib Revenue (Value) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Alectinib Type and Applications
Table Roche Alectinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Everest Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Everest Pharmaceuticals Alectinib Type and Applications
Table Everest Pharmaceuticals Alectinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Alectinib Sales by Manufacturer (2017-2018)
Figure Global Alectinib Sales Market Share by Manufacturer in 2017
Figure Global Alectinib Sales Market Share by Manufacturer in 2018
Table Global Alectinib Revenue by Manufacturer (2017-2018)
Figure Global Alectinib Revenue Market Share by Manufacturer in 2017
Figure Global Alectinib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Alectinib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Alectinib Manufacturer (Revenue) Market Share in 2018
Figure Global Alectinib Sales and Growth Rate (2014-2019)
Figure Global Alectinib Revenue and Growth Rate (2014-2019)
Table Global Alectinib Sales by Regions (2014-2019)
Table Global Alectinib Sales Market Share by Regions (2014-2019)
Table Global Alectinib Revenue by Regions (2014-2019)
Figure Global Alectinib Revenue Market Share by Regions (2014-2019)
Figure Global Alectinib Revenue Market Share by Regions in 2018
Figure North America Alectinib Sales and Growth Rate (2014-2019)
Figure Europe Alectinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Alectinib Sales and Growth Rate (2014-2019)
Figure South America Alectinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Alectinib Sales and Growth Rate (2014-2019)
Figure North America Alectinib Revenue and Growth Rate (2014-2019)
Table North America Alectinib Sales by Countries (2014-2019)
Table North America Alectinib Sales Market Share by Countries (2014-2019)
Figure North America Alectinib Sales Market Share by Countries (2014-2019)
Figure North America Alectinib Sales Market Share by Countries in 2018
Table North America Alectinib Revenue by Countries (2014-2019)
Table North America Alectinib Revenue Market Share by Countries (2014-2019)
Figure North America Alectinib Revenue Market Share by Countries (2014-2019)
Figure North America Alectinib Revenue Market Share by Countries in 2018
Figure United States Alectinib Sales and Growth Rate (2014-2019)
Figure Canada Alectinib Sales and Growth Rate (2014-2019)
Figure Mexico Alectinib Sales and Growth Rate (2014-2019)
Figure Europe Alectinib Revenue and Growth Rate (2014-2019)
Table Europe Alectinib Sales by Countries (2014-2019)
Table Europe Alectinib Sales Market Share by Countries (2014-2019)
Table Europe Alectinib Revenue by Countries (2014-2019)
Figure Europe Alectinib Revenue Market Share by Countries (2014-2019)
Figure Europe Alectinib Revenue Market Share by Countries in 2018
Figure Germany Alectinib Sales and Growth Rate (2014-2019)
Figure UK Alectinib Sales and Growth Rate (2014-2019)
Figure France Alectinib Sales and Growth Rate (2014-2019)
Figure Russia Alectinib Sales and Growth Rate (2014-2019)
Figure Italy Alectinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Alectinib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Alectinib Sales by Countries (2014-2019)
Table Asia-Pacific Alectinib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Alectinib Sales Market Share by Countries 2018
Table Asia-Pacific Alectinib Revenue by Countries (2014-2019)
Figure Asia-Pacific Alectinib Revenue Market Share by Countries 2018
Figure China Alectinib Sales and Growth Rate (2014-2019)
Figure Japan Alectinib Sales and Growth Rate (2014-2019)
Figure Korea Alectinib Sales and Growth Rate (2014-2019)
Figure India Alectinib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Alectinib Sales and Growth Rate (2014-2019)
Figure South America Alectinib Revenue and Growth Rate (2014-2019)
Table South America Alectinib Sales by Countries (2014-2019)
Table South America Alectinib Sales Market Share by Countries (2014-2019)
Figure South America Alectinib Sales Market Share by Countries in 2018
Table South America Alectinib Revenue by Countries (2014-2019)
Table South America Alectinib Revenue Market Share by Countries (2014-2019)
Figure South America Alectinib Revenue Market Share by Countries in 2018
Figure Brazil Alectinib Sales and Growth Rate (2014-2019)
Figure Argentina Alectinib Sales and Growth Rate (2014-2019)
Figure Colombia Alectinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Alectinib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Alectinib Sales by Countries (2014-2019)
Table Middle East and Africa Alectinib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Alectinib Sales Market Share by Countries in 2018
Table Middle East and Africa Alectinib Revenue by Countries (2014-2019)
Table Middle East and Africa Alectinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Alectinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Alectinib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Alectinib Sales and Growth Rate (2014-2019)
Figure UAE Alectinib Sales and Growth Rate (2014-2019)
Figure Egypt Alectinib Sales and Growth Rate (2014-2019)
Figure Nigeria Alectinib Sales and Growth Rate (2014-2019)
Figure South Africa Alectinib Sales and Growth Rate (2014-2019)
Table Global Alectinib Sales by Type (2014-2019)
Table Global Alectinib Sales Share by Type (2014-2019)
Table Global Alectinib Revenue by Type (2014-2019)
Table Global Alectinib Revenue Share by Type (2014-2019)
Figure Global 150mg*140 Capsules Sales Growth (2014-2019)
Figure Global 150mg*140 Capsules Price (2014-2019)
Figure Global 150mg*28 Capsules Sales Growth (2014-2019)
Figure Global 150mg*28 Capsules Price (2014-2019)
Figure Global 20mg*1 Capsule Sales Growth (2014-2019)
Figure Global 20mg*1 Capsule Price (2014-2019)
Figure Global 40mg*1 Capsule Sales Growth (2014-2019)
Figure Global 40mg*1 Capsule Price (2014-2019)
Figure Global 150mg*26 Capsules Sales Growth (2014-2019)
Figure Global 150mg*26 Capsules Price (2014-2019)
Table Global Alectinib Sales by Application (2014-2019)
Table Global Alectinib Sales Share by Application (2014-2019)
Figure Global Advanced NSCLC Sales Growth (2014-2019)
Figure Global Recurrent NSCLC Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Alectinib Sales, Revenue and Growth Rate (2019-2024)
Table Global Alectinib Sales Forecast by Regions (2019-2024)
Table Global Alectinib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Alectinib Market Forecast (2019-2024)
Figure Europe Sales Alectinib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Alectinib Market Forecast (2019-2024)
Figure South America Sales Alectinib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Alectinib Market Forecast (2019-2024)
Table Global Alectinib Sales Forecast by Type (2019-2024)
Table Global Alectinib Market Share Forecast by Type (2019-2024)
Table Global Alectinib Sales Forecast by Application (2019-2024)
Table Global Alectinib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
ニネタニブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Nintedanib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Nintedanib in global market,…- NSCLC用標的薬物ALK阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug ALK Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…
- NSCLC用標的薬物MEK阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug MEK Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…
- HPMCカプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） HPMC Capsules are two-piece capsules made from cellulosic raw materials that satisfy vegetarian, religion, cultural and policy needs. These vegetable capsules are an attractive, all natural dosage form that retain all the advantages - easy to swallow, effectively mask taste and odor, and allow produ…
- ゼラチン系カプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Gelatin Based Capsules is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Gelatin Based Capsules in …